Welcome to this Fall edition of the SCLC newsletter!
On the science front, researchers continue to pursue improved treatments for this type of lung cancer, including various combinations of immunotherapy and chemotherapy. Efforts are also underway to develop blood tests that could help diagnose SCLC and to identify biomarkers that may lead to more targeted treatments, similar to what we currently see for NSCLC. Indeed, SCLC remains an area of intense study to develop improved diagnosis and treatments to improve patient outcomes.
Take a look at some of recent research news in small cell lung cancer (SCLC).
And don't forget to check out the useful resources for SCLC survivors and their caregivers!
Research News
Technology.org
Scientists unlock potential for a small cell lung cancer blood test
Published Aug 26, 2022
The Podcast Park [Newswire]
AMGEN PRESENTS NEW TARLATAMAB CLINICAL DATA AT WCLC 2022
Published Aug 9, 2022
Pharmacy Times
Switching to Lurbinectedin Monotherapy Maintains, Improves Tumor Response for Relapsed Small Cell Lung Cancer
Published Jun 8, 2022
The Clanton Advertiser
Data Presented at ASCO Demonstrate Trilaciclib Helps Protect Against Severe Neutropenia, Severe Anemia, and Severe Thrombocytopenia When Given to Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Patients Prior to Chemotherapy
Published Jun 2, 2022
Resources for SCLC Survivors & Caregivers
Top 5 Caregiver Must-Haves
Caregiver Resources Starter Kit: 5 Resources Caregivers Should Access upon their Loved One’s Diagnosis | Navigating Small Cell
Connect with Other Lung Cancer Survivors & Caregivers
Get to know LUNGevity’s Lung Cancer Support Services | Navigating Small Cell
What is SCLC? Up-to-date Information at Your Fingertips
About Small Cell Lung Cancer | Navigating Small Cell
If you need further assistance, please email us at support@lungevity.org. Our team is always here to assist you.
